Hepatocellular carcinoma reduces ATXN7L3 to evade estrogen-dependent growth suppression.
作者信息
Bean Joe, Mohan Ryan D
机构信息
School of Biological and Chemical Sciences, Division of Genetics, Developmental and Evolutionary Biology, University of Missouri - Kansas City, MO, USA.
School of Biological and Chemical Sciences, Division of Genetics, Developmental and Evolutionary Biology, University of Missouri - Kansas City, MO, USA.
出版信息
EBioMedicine. 2021 Jan;63:103179. doi: 10.1016/j.ebiom.2020.103179. Epub 2020 Dec 16.
Abstract
摘要
相似文献
1
Hepatocellular carcinoma reduces ATXN7L3 to evade estrogen-dependent growth suppression.肝细胞癌通过降低ATXN7L3来逃避雌激素依赖性生长抑制。
EBioMedicine. 2021 Jan;63:103179. doi: 10.1016/j.ebiom.2020.103179. Epub 2020 Dec 16.
2
ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function.ATXN7L3 通过负向调控 SMAD7 转录抑制肝癌生长。
EBioMedicine. 2020 Dec;62:103108. doi: 10.1016/j.ebiom.2020.103108. Epub 2020 Nov 11.
3
MACC 1 as a marker for vascular invasive hepatocellular carcinoma.MACC1 作为血管侵犯型肝细胞癌的标志物。
Anticancer Res. 2011 Mar;31(3):777-80.
4
G6PC expression is downregulated in hepatocellular carcinoma and associated with malignancy progression.
Asian J Surg. 2024 Aug;47(8):3727-3729. doi: 10.1016/j.asjsur.2024.04.099. Epub 2024 May 3.
5
Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.下调蓖麻锌指蛋白 1 可预测不良预后并通过 MAPK/ERK 信号通路促进肝癌进展。
J Exp Clin Cancer Res. 2018 Mar 5;37(1):45. doi: 10.1186/s13046-018-0720-8.
6
[Expression characteristics and clinical significance of microRNA-29a in hepatocellular carcinoma tissues].
Zhonghua Gan Zang Bing Za Zhi. 2019 Nov 20;27(11):896-898. doi: 10.3760/cma.j.issn.1007-3418.2019.11.014.
7
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.Mybl2 的表达受遗传控制，并有助于决定肝癌易感表型。
J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7.
8
ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.ZBP-89 和 Sp1 促进肝癌细胞中 Bak 的表达。
BMC Cancer. 2018 Apr 13;18(1):419. doi: 10.1186/s12885-018-4349-y.
9
MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.微小RNA-301a-3p通过靶向VGLL4抑制肝细胞癌进展。
Pathol Res Pract. 2018 Dec;214(12):2039-2045. doi: 10.1016/j.prp.2018.09.008. Epub 2018 Sep 15.
10
Activation of c-Yes in hepatocellular carcinoma: a preliminary study.c-Yes在肝细胞癌中的激活：一项初步研究。
World J Gastroenterol. 2006 Sep 21;12(35):5743-5. doi: 10.3748/wjg.v12.i35.5743.
引用本文的文献
1
Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy.肝细胞癌免疫治疗中的性别差异：激素和基因对治疗效果的影响。
Front Immunol. 2025 May 14;16:1607374. doi: 10.3389/fimmu.2025.1607374. eCollection 2025.
2
Overexpression Leads to Aberrant Signal Transduction of Cancer-Related Pathways but Is Not Sufficient to Drive Tumor Formation in Mice.过表达导致癌症相关信号通路的异常转导，但不足以驱动小鼠肿瘤形成。
Cancers (Basel). 2021 Aug 25;13(17):4276. doi: 10.3390/cancers13174276.
Zotero 插件